The 3rd EU HCV Policy Virtual Summit on 24 March 2021 explores barriers to elimination
Despite the progress that’s been made in recent years, viral hepatitis remains a serious public health threat worldwide. In the World Health Organization (WHO) European region an estimated 15 million people are living with chronic hepatitis B, and 14 million people are living with hepatitis C. The public health threat of hepatitis has been exacerbated by the COVID-19 pandemic with many countries reporting disruption to hepatitis services due to strained healthcare systems and shifting priorities, putting the 2030 elimination goals in jeopardy.
The third EU HCV Policy Summit will bring together policy-makers, experts, members of parliament, directors of national hepatitis C elimination plans, mayors, patient associations, clinicians and Members of the European Parliament to raise awareness on the state of play regarding the goal of hepatitis C by 2030 and showcase best practices as well as indicate what policy actions are needed to get more countries on track to achieve hepatitis C elimination by 2030. The summit is taking place on Wednesday 24 March 2021 from 14:00 to 18:15 CET.
Mr Alexis Goosdeel, Director, European Monitoring Centre for Drugs & Drug Addiction (EMCDDA)
Dr. Pilar Aparicio Azcárraga, MD, PhD, Director General of Public Health, Ministry of Health, Spain
Dr. Yuval Dadon, MD MBA, Ministry of Health, Israel
Dr Antons Mozalevskis, MD, Joint Tuberculosis, HIV and Viral Hepatitis Programme, Regional Office for Europe, World Health Organization, Copenhagen, Denmark
Dr. Ricardo Baptista Leite, MP, MD, Ph, National Parliament Portugal & UNITE – Global Parliamentarians Network
Dr. Homie Razavi, Center for Disease Analysis, Lafayette, CO USA
Prof. Angelos Hatzakis MD, PhD, MSc, Medical School of National and Kapodistrian University of Athens, Greece
Prof. Nurdan Tözün MD, FRCP, Acibadem University School of Medicine, Istanbul, Turkey
For a full list of speakers and chairs please click here.
For draft programme please click here.
For free registration please click here.
Urgent action is needed to tackle hepatitis B stigma and discrimination, according to a new report released by the World Hepatitis Alliance (WHA).
Urgent action is needed to tackle hepatitis B stigma and discrimination Across the world, stigma and discrimination impact people living with hepatitis B, with careers